PriceTargets.com logo

Craneware - CRW Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 2,800
  • Forecasted Upside: 51.56%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
GBX 1,847.50 As of 03/25/2025 01:42 PM ET
▼ -12.5 (-0.67%)

This chart shows the closing price for CRW by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
JanFebMar1,847.50Closing price on 03/25/25:
Get New Craneware Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CRW and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CRW

Analyst Price Target is GBX 2,800
▲ +51.56% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Craneware in the last 3 months. The average price target is GBX 2,800, with a high forecast of GBX 2,800 and a low forecast of GBX 2,800. The average price target represents a 51.56% upside from the last price of GBX 1,847.50.

This chart shows the closing price for CRW for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
3/246/249/2412/243/254/261.19k1.59k2k2.40k2.80kClosing price on 03/25/25: 1,847.50High2.80kAverage2.80kLow2.80k




Current Consensus is Buy

The current consensus among 2 investment analysts is to buy stock in Craneware. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/3/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/1/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2025

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/11/2025Berenberg BankReiterated RatingBuyGBX 2,800
3/11/2025Shore CapitalReiterated RatingBuy
12/10/2024Shore CapitalReiterated RatingBuy
9/3/2024Berenberg BankReiterated RatingBuyGBX 2,700
7/18/2024Berenberg BankBoost TargetBuyGBX 2,600 ➝ GBX 2,700
7/2/2024Berenberg BankReiterated RatingBuyGBX 2,600
3/4/2024Berenberg BankBoost TargetBuyGBX 2,300 ➝ GBX 2,600
9/5/2023Berenberg BankReiterated RatingBuyGBX 2,300
3/6/2023Shore CapitalReiterated RatingBuyGBX 2,300
9/20/2022Berenberg BankBoost TargetBuyGBX 2,320 ➝ GBX 2,600
7/26/2022Berenberg BankLower TargetBuyGBX 2,725 ➝ GBX 2,320
3/22/2022Berenberg BankReiterated RatingBuyGBX 2,725
3/14/2022Berenberg BankLower TargetBuyGBX 3,100 ➝ GBX 2,725
2/1/2022Berenberg BankReiterated RatingBuyGBX 3,100
12/1/2021Berenberg BankReiterated RatingBuyGBX 3,100
11/4/2021Berenberg BankBoost TargetBuyGBX 2,750 ➝ GBX 3,100
6/11/2021Berenberg BankReiterated RatingBuyGBX 2,420
3/1/2021Berenberg BankBoost TargetBuyGBX 2,200 ➝ GBX 2,420
7/9/2020Berenberg BankReiterated RatingBuy
7/8/2020Peel HuntReiterated RatingBuy
6/5/2020Berenberg BankReiterated RatingBuyGBX 2,200
4/16/2020Peel HuntReiterated RatingBuy
3/31/2020Berenberg BankLower TargetBuyGBX 2,500 ➝ GBX 2,200
(Data available from 3/26/2020 forward)

News Sentiment Rating

0.49 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2024
  • 4 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
1/25/2025
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2025
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2025

Current Sentiment

  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Craneware logo
The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.
Read More

Today's Range

Now: GBX 1,847.50
Low: 1,830
High: 1,900

50 Day Range

MA: GBX 1,915.90
Low: 1,738.40
High: 2,098

52 Week Range

Now: GBX 1,847.50
Low: 1,670
High: 2,509.20

Volume

118,002 shs

Average Volume

88,161 shs

Market Capitalization

£793.81 million

P/E Ratio

68.26

Dividend Yield

1.44%

Beta

0.28

Frequently Asked Questions

What sell-side analysts currently cover shares of Craneware?

The following Wall Street analysts have issued reports on Craneware in the last year: Berenberg Bank, and Shore Capital.
View the latest analyst ratings for CRW.

What is the current price target for Craneware?

0 Wall Street analysts have set twelve-month price targets for Craneware in the last year. Their average twelve-month price target is GBX 2,800, suggesting a possible upside of 51.6%. Berenberg Bank has the highest price target set, predicting CRW will reach GBX 2,800 in the next twelve months. Berenberg Bank has the lowest price target set, forecasting a price of GBX 2,800 for Craneware in the next year.
View the latest price targets for CRW.

What is the current consensus analyst rating for Craneware?

Craneware currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CRW will outperform the market and that investors should add to their positions of Craneware.
View the latest ratings for CRW.

What other companies compete with Craneware?

Other companies that are similar to Craneware include EMIS Group, Instem, Kooth, Renalytix and Cambridge Cognition. Learn More about companies similar to Craneware.

How do I contact Craneware's investor relations team?

Craneware's physical mailing address is 1 Tanfield, EDINBURGH, EH3 5DA, United Kingdom. The company's listed phone number is +44-131-5503100. The official website for Craneware is public.craneware.com. Learn More about contacing Craneware investor relations.